Last Updated: June 25, 2026

FLURAZEPAM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Flurazepam patents expire, and what generic alternatives are available?

Flurazepam is a drug marketed by Chartwell Rx, Halsey, Hikma Intl Pharms, Novitium Pharma, Purepac Pharm, Rising, Sun Pharm Industries, Superpharm, Usl Pharma, and Warner Chilcott. and is included in twenty-one NDAs.

The generic ingredient in FLURAZEPAM is flurazepam hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the flurazepam hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Flurazepam

A generic version of FLURAZEPAM was approved as flurazepam hydrochloride by RISING on November 27th, 1985.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for FLURAZEPAM?
  • What are the global sales for FLURAZEPAM?
  • What is Average Wholesale Price for FLURAZEPAM?
Summary for FLURAZEPAM
US Patents:0
Applicants:10
NDAs:21
Drug Prices: Drug price information for FLURAZEPAM
DailyMed Link:FLURAZEPAM at DailyMed

US Patents and Regulatory Information for FLURAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071205-001 Nov 25, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Industries FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 070455-001 Aug 4, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Warner Chilcott FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071768-001 Dec 4, 1987 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma Intl Pharms FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071108-002 Dec 8, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
DrugChatter Q&A for FLURAZEPAM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.